MLYS- Mineralys Therapeutics, Inc.

Name: Mineralys Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Mineralys Therapeutics, Inc. (MLYS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. MLYS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Slingsby Brian Taylor	7.90M	$206.92M	-
Dir	Ra Capital Management, L.P.	5.46M	$142.85M	-
CEO	Congleton Jon	689.3K	$18.05M	-
Dir	Akkaraju Srinivas	588.2K	$15.40M	-
Other	Rodman David Malcom	57.1K	$1.49M	-14,474

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 12, 2026	Rodman David Malcom56	Chief Medical Officer	Sale+OE	8,518	$32.56	$277,339.14	-6.4%	-19.3%	-
Jan 5, 2026	Rodman David Malcom56	Chief Medical Officer	Sale+OE	262,752	$35.25	$9,261,028.10	-51.6%	-20.8%	-
Nov 20, 2025	Slingsby Brian Taylor48	Director, 10% Owner	Sell	1,000,000	$43.35	$43,350,000.00	-11.2%	-33.3%	-
Nov 13, 2025	Karydas Daphne	Director	Sale+OE	15,000	$45.99	$689,797.08	-75.4%	-32.8%	-
Nov 13, 2025	Gold Alexander M61	Director	Sale+OE	34,675	$45.45	$1,576,094.67	-83.3%	-32.8%	-
Nov 11, 2025	Congleton Jon47	Chief Executive Officer	Sell	200,000	$45.44	$9,088,498.87	-4.3%	-32.6%	-
Nov 11, 2025	Levy Adam Scott	CFO And Secretary	Sale+OE	119,524	$44.88	$5,363,715.88	-12.1%	-32.6%	-
Oct 15, 2025	Rodman David Malcom56	Chief Medical Officer	Sell	10,369	$43.01	$445,982.10	-12.7%	-24.0%	-
Oct 13, 2025	Levy Adam Scott	CFO And Secretary	Sell	10,758	$42.01	$451,983.56	-4.3%	-23.4%	-
Oct 13, 2025	Congleton Jon47	Chief Executive Officer	Sell	15,100	$42.67	$644,326.87	-0.9%	-23.4%	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC